Dare Bioscience DARE
NASDAQ DARE
$0.69 +0.01 (+1.47%)
At close: Nov 10, 2026 · 4:00 PM EST

Dare Bioscience (DARE) Goodwill impairment charges (2018)

Updated

Dare Bioscience's Goodwill impairment charges was $5.19 million in FY2018, down 30.8% from $7.5 million in FY2017.

Analysis

Dare Bioscience (DARE) Goodwill impairment charges (2018) Analysis & Trends

  • Per Business Quant data, Goodwill impairment charges in earlier years was $7.5 million in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Dare Bioscience 10.47 Mn -68.48 Mn -132,343.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 5.20 Mn
API Access

Dare Bioscience Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=DARE&period=max&api_key=YOUR_API_KEY